16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
The lowered threshold for foreign direct investments into France will apply to non-EU and non-EEA in...
Read More >
• A payment to a government official can take many forms. • The SEC charges bank for books and re...
Read More >
On October 18, 2019, the US Court of Appeals for the Federal Circuit affirmed the Armed Services Boa...
Read More >
Healthcare businesses represent essential transaction opportunities in the middle market. Despite th...
Read More >
On March 13, 2020, President Trump declared a national emergency in response to the coronavirus (COV...
Read More >
If you want to make God laugh, tell him your plans, so the joke goes. But acts of God are often are ...
Read More >